| Rosalind D Leaming, MD | |
|
3125 S Scatterfield Rd, Suite 310, Anderson, IN 46013-1801 | |
| (317) 621-1006 | |
| (317) 355-6822 |
| Full Name | Rosalind D Leaming |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 3125 S Scatterfield Rd, Anderson, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205802600 | NPI | - | NPPES |
| P00966918 | Other | IN | RR MEDICARE |
| 000000701134 | Other | IN | ANTHEM |
| 200149640 | Medicaid | IN | |
| 000000342150 | Other | IN | ANTHEM |
| P01678718 | Other | IN | MEDICARE RR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 01030305A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosalind D Leaming, MD 6626 E 75th St, Suite 500, Indianapolis, IN 46250-2805 Ph: () - | Rosalind D Leaming, MD 3125 S Scatterfield Rd, Suite 310, Anderson, IN 46013-1801 Ph: (317) 621-1006 |
News Archive
The Bill & Melinda Gates Foundation has awarded a new grant to Duke University Medical Center for work developing vaccines that can induce IgA antibodies for preventing HIV-1 infection. This award comes from the Gates' Collaboration for AIDS Vaccine Discovery (CAVD) program.
Abbot and AstraZeneca have announced that they have entered into an agreement for AstraZeneca to co-promote Abbott's Trilipix (fenofibric acid), a medication for use alone or in combination with a statin to treat certain lipid disorders. Under the terms of the agreement, AstraZeneca will obtain the non-exclusive right to co-promote Trilipix alongside Abbott in the United States, excluding Puerto Rico. Specific financial terms were not disclosed.
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.
All infant formulas, whether ready-to-feed, concentrated or organic, contain fluoride at levels which can discolor developing teeth, reports the October 2009 Journal of the American Dental Association (JADA)(1).
› Verified 2 days ago
Mark Randall Jennings, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Chad Michael Feldman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |